Ibuprofen and Biomarkers of Acute Kidney Injury After Running in the Heat - Trial NCT06247462
Access comprehensive clinical trial information for NCT06247462 through Pure Global AI's free database. This Phase 1 trial is sponsored by University of New Mexico and is currently Completed. The study focuses on Acute Kidney Injury. Target enrollment is 12 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of New Mexico
Timeline & Enrollment
Phase 1
Jun 01, 2023
Sep 05, 2023
Primary Outcome
Biomarkers of Acute Kidney Injury from Ibuprofen Ingestion Prior to Exercise in the Heat
Summary
The goal of this study is to determine if ibuprofen prior to exercise in the heat worsens
 biomarkers of acute kidney injury. Participants were given 600mg of ibuprofen or placebo
 (corn starch) 12- and 1-hour prior to running for 1-hour in a hot environment (35°C) at
 moderate intensity. Urine, plasma, and serum samples were collected pre-, post-, and 1hour
 post-exercise to assess biomarkers of acute kidney injury. This was a double blind,
 randomized crossover design, so that participants completed the alternate trial (ibuprofen or
 placebo) at least seven days later.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06247462
Non-Device Trial